- Home
- BBGI vs ADXN Comparison
BBGI vs ADXN Comparison
Compare BBGI & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBGI
- ADXN
- Stock Information
- Founded
- BBGI 1961
- ADXN 2002
- Country
- BBGI United States
- ADXN Switzerland
- Employees
- BBGI N/A
- ADXN N/A
- Industry
- BBGI Broadcasting
- ADXN Biotechnology: Pharmaceutical Preparations
- Sector
- BBGI Consumer Discretionary
- ADXN Health Care
- Exchange
- BBGI Nasdaq
- ADXN Nasdaq
- Market Cap
- BBGI 10.0M
- ADXN 8.5M
- IPO Year
- BBGI 2000
- ADXN N/A
- Fundamental
- Price
- BBGI $5.61
- ADXN $9.60
- Analyst Decision
- BBGI
- ADXN
- Analyst Count
- BBGI 0
- ADXN 0
- Target Price
- BBGI N/A
- ADXN N/A
- AVG Volume (30 Days)
- BBGI 29.0K
- ADXN 24.3K
- Earning Date
- BBGI 11-12-2025
- ADXN 11-21-2025
- Dividend Yield
- BBGI N/A
- ADXN N/A
- EPS Growth
- BBGI N/A
- ADXN N/A
- EPS
- BBGI N/A
- ADXN N/A
- Revenue
- BBGI $227,387,784.00
- ADXN $210,347.00
- Revenue This Year
- BBGI $5.02
- ADXN $86.57
- Revenue Next Year
- BBGI N/A
- ADXN N/A
- P/E Ratio
- BBGI N/A
- ADXN N/A
- Revenue Growth
- BBGI N/A
- ADXN N/A
- 52 Week Low
- BBGI $3.67
- ADXN $6.51
- 52 Week High
- BBGI $14.95
- ADXN $12.05
- Technical
- Relative Strength Index (RSI)
- BBGI 48.61
- ADXN 53.29
- Support Level
- BBGI $5.50
- ADXN $8.67
- Resistance Level
- BBGI $7.02
- ADXN $10.55
- Average True Range (ATR)
- BBGI 0.33
- ADXN 0.81
- MACD
- BBGI -0.04
- ADXN 0.02
- Stochastic Oscillator
- BBGI 7.49
- ADXN 31.30
About BBGI Beasley Broadcast Group Inc.
Beasley Broadcast Group Inc is a multi-platform media company, whose primary business is operating radio stations throughout the United States. The company offers local and national advertisers integrated marketing solutions across audio, digital and event platforms. It owns and operates stations in the following markets: Atlanta, GA, Augusta, GA, Boston, MA, Charlotte, NC, Detroit, MI, Fayetteville, NC, Fort Myers-Naples, FL, Las Vegas, NV, Middlesex, NJ, Monmouth, NJ, Morristown, NJ, Philadelphia, PA, Tampa-Saint Petersburg, FL, and Wilmington, DE. The company operates in two segments Audio and Digital.
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.